Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 7/20 | 0.54 |
| ▸ | CA1 | P00915 | 5/20 | 0.54 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.38 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.38 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.38 |
| ▸ | USP2 | O75604 | 2/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.31 |
| ▸ | ECE1 | P42892 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA3 | P07451 | 1/20 | 0.31 |
| ▸ | CA4 | P22748 | 1/20 | 0.31 |
| ▸ | CA6 | P23280 | 1/20 | 0.31 |
| ▸ | CA5A | P35218 | 1/20 | 0.31 |
| ▸ | CA7 | P43166 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.31 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18737 | 0.83 | — | — | |
| SCHEMBL293079 | 0.83 | CA1 (0.39) | CA2CA1USP2ALOX15ECE1 | |
| SCHEMBL19192783 | 0.82 | CA2 (0.41) | CA2CA1SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL4756185 | 0.82 | SLC1A3 (0.52) | CA2CA1SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL4756180 | 0.82 | SLC1A3 (0.52) | CA2CA1SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL16683908 | 0.82 | SLC1A3 (0.52) | CA2CA1SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL27806629 | 0.81 | CA1 (0.42) | CA2CA1SLC1A3SLC1A2SLC1A1 | |
| Hydrochloric Acid SCHEMBL530588 | 0.80 | — | — | |
| SCHEMBL28601320 | 0.80 | CA1 (0.37) | CA2CA1USP2ALOX15LMNA | |
| SCHEMBL3178200 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101591298-A | Contain 1, hydroxamic acid derivatives, the Preparation Method And The Use of 3-two assorted five-membered ring fused benzenes | TIANJIN INST PHARM RESEARCH (CN) | 2009-12-02 | — | — | CN | claimed |
| US-20260108617-A1 | AUTO-TUNING DRUG REGULATOR CONSTRUCTIONS | RETHINK64 BIONETWORKS PBC (US) | 2026-04-23 | — | — | US | disclosed |
| WO-2024155707-A1 | AUTO-TUNING DRUG REGULATOR CONSTRUCTIONS | RETHINK64 BIONETWORKS PBC (US) | 2024-07-25 | — | — | WO | disclosed |
| CN-111526891-B | Pharmaceutical raw material or pharmaceutical additive and pharmaceutical raw material or pharmaceutical using the same | 三洋化成工业株式会社 | 2023-10-20 | — | — | CN | disclosed |
| CN-116874440-A | Synthesis and application of isoxazoline-containing derivative | 贵州大学 | 2023-10-13 | — | — | CN | disclosed |
| WO-2021195183-A1 | COMPOSITIONS AND METHODS FOR INHIBITING PROTEIN EMBRYONIC ECTODERM DEVELOPMENT ACTIVITY AND TREATING DISEASE | EXO THERAPEUTICS, INC. (US) | 2021-09-30 | — | — | WO | disclosed |
| EP-2102148-B1 | NOVEL BIS(DIALKYLAMIDE) COMPOUNDS, PROCESS FOR THE PREPARATION THEREOF AND USES THEREOF | RHODIA OPERATIONS (FR) | 2015-09-16 | — | — | EP | disclosed |
| EP-2802631-A1 | REVERSIBLE THERMOCHROMIC AND PHOTOCHROMIC INK PENS AND MARKERS | Chromatic Technologies, Inc. (US) | 2014-11-19 | — | — | EP | disclosed |
| WO-2013106420-A1 | REVERSIBLE THERMOCHROMIC AND PHOTOCHROMIC INK PENS AND MARKERS | CHROMATIC TECHNOLOGIES, INC. (US) | 2013-07-18 | — | — | WO | disclosed |
| CN-101591298-A | Contain 1, hydroxamic acid derivatives, the Preparation Method And The Use of 3-two assorted five-membered ring fused benzenes | TIANJIN INST PHARM RESEARCH (CN) | 2009-12-02 | — | — | CN | disclosed |
| EP-2102148-A1 | NOVEL BIS(DIALKYLAMIDE) COMPOUNDS, PROCESS FOR THE PREPARATION THEREOF AND USES THEREOF | Rhodia Opérations (FR) | 2009-09-23 | — | — | EP | disclosed |
| WO-2008074837-A1 | NOVEL BIS(DIALKYLAMIDE) COMPOUNDS, PROCESS FOR THE PREPARATION THEREOF AND USES THEREOF | RHODIA OPERATIONS (FR) | 2008-06-26 | — | — | WO | disclosed |
| EP-1812439-A2 | KINASE INHIBITORS | Takeda San Diego, Inc. (US) | 2007-08-01 | — | — | EP | disclosed |
| WO-2006044687-A2 | KINASE INHIBITORS | TAKEDA SAN DIEGO, INC. (US) | 2006-04-27 | — | — | WO | disclosed |
| WO-2005019177-A1 | AMINOPIPERIDINE AMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF | ICOS CORPORATION (US) | 2005-03-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260108617-A1 | AUTO-TUNING DRUG REGULATOR CONSTRUCTIONS | TPMT, CYP2D6, ACHE | CA2 1324/4885CA1 2228/4885SLC1A3 2787/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.